Presence of benznidazole conjugated metabolites in urine identified by β-glucuronidase treatment
Chagas disease is a serious public health problem in Latin America and, due to migration, in other nonendemic regions. Benznidazole (BNZ) is first choice drug in pediatric therapeutics. However, little is known regarding its metabolism in humans. The aim of the study was to isolate and identify prod...
Guardado en:
| Autores principales: | Marson, María Elena, García Bournissen, Facundo, Altcheh, Jaime, Moscatelli, Guillermo, Moroni, Samantha, Mastrantonio Garrido, Guido Enrique |
|---|---|
| Formato: | Articulo |
| Lenguaje: | Español |
| Publicado: |
2020
|
| Materias: | |
| Acceso en línea: | http://sedici.unlp.edu.ar/handle/10915/121849 |
| Aporte de: |
Ejemplares similares
-
Development of UV/HPLC methods for quantitative analysis of benznidazole in human plasma and urine for application in pediatric clinical studies
por: Marson, María Elena, et al.
Publicado: (2013) -
A Simple and Efficient HPLC Method for Benznidazole Dosage in Human Breast Milk
por: Marson, María Elena, et al.
Publicado: (2013) -
Benznidazole levels in blood vary with age in rats
por: Bulffer, Romina Fernanda, et al.
Publicado: (2011) -
Pharmacokinetic and pharmacodynamic responses in adult patients with chagas disease treated with a new formulation of benznidazole
por: Fernández, Marisa Liliana, et al.
Publicado: (2016) -
Identification of N-benzylacetamide as a major component of human plasmatic metabolic profiling of benznidazole
por: Marson, María Elena, et al.
Publicado: (2015)